COMPARING THE EFFECT OF AN AROMATASE INHIBITOR (LETROZOL) plus CABERGOLINE AND LETROZOL ALONE ON UTERINE MYOMA REGRESSION

被引：0
|
作者：
Sayyah-Melli, M. [1 ]
Rahmani, V. [2 ]
Mobasseri, M. [2 ]
机构：
[1] Tabriz Univ Med Sci, Womens Reprod Hlth Res Ctr, Ob & Gyn, Tabriz, Iran
[2] Tabriz Univ Med Sci, Ob & Gyn, Tabriz, Iran
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2016年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCS-0089
引用
收藏
页码：951 / 951
页数：1
相关论文
共 37 条
  • [31] Randomized phase II study of metronomic chemotherapy (MC) plus aromatase inhibitor (AI) versus MC alone in postmenopausal hormone receptor-positive, metastatic breast cancer (MBC), with correlative circulating endothelial cell (CEC), circulating endothelial progenitor cell (CEP), VEGF, and VEGFR levels
    Wong, N.
    Hui, K.
    Sun, F.
    Yap, Y.
    Ng, R. C.
    Chia, J. W.
    Ngo, L.
    Lo, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [32] Comparing the effect of adjunctive N-acetylcysteine plus low dose contraceptive with low dose contraceptive alone on recurrence of ovarian endometrioma and chronic pelvic pain after conservative laparoscopic surgery: a randomised clinical trial study
    Asgari, Zahra
    Moini, Ashraf
    Montazeri, Ali
    Tavoli, Zahra
    Hosseini, Ladan
    Hosseini, Reihaneh
    Tehranian, Afsaneh
    Karimi, Rana
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (05) : 1493 - 1497
  • [33] Comparing the effect of STan (cardiotocographic electronic fetal monitoring (CTG) plus analysis of the ST segment of the fetal electrocardiogram) with CTG alone on emergency caesarean section rates: study protocol for the STan Australian Randomised controlled Trial (START)
    D. Turnbull
    A. Salter
    B. Simpson
    B. W. Mol
    E. Chandraharan
    A. McPhee
    I. Symonds
    M. Benton
    S. Kuah
    G. Matthews
    K. Howard
    C. Wilkinson
    Trials, 20
  • [34] Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy
    Nakamura, Kazuhiko
    Ihara, Eikichi
    Akiho, Hirotada
    Akahoshi, Kazuya
    Harada, Naohiko
    Ochiai, Toshiaki
    Nakamura, Norimoto
    Ogino, Haruei
    Iwasa, Tsutomu
    Aso, Akira
    Iboshi, Yoichiro
    Takayanagi, Ryoichi
    GUT AND LIVER, 2016, 10 (06) : 917 - 924
  • [35] Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (>=N2, M0) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival
    Cvitkovic, E
    Eschwege, F
    Rahal, M
    Dosen
    Mersic, Z
    Krajina, Z
    Armand, JP
    Bouhris, J
    TubianaMathieu, M
    Fountzilas, G
    Kosmidis, PA
    Prasad, U
    Ganesan, S
    ElGueddari, B
    Bachouchi, M
    Mansouri, A
    Oliveira, J
    Raposo, J
    Wierzbicki, R
    Lianes, P
    Pena, C
    Onat, H
    Altun, M
    Benhamou, E
    Ducourtieux, M
    Azli, N
    Fandi, A
    Taamma, A
    Bosq, J
    Klijanienko, J
    Sigal, R
    Hong, WK
    Vokes, EE
    Clark, JR
    LeFloch, O
    Bernier, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (03): : 463 - 469
  • [36] Protective effect of valsartan alone and in combination with neprilysin inhibitor (valsartan plus sacubitril) against hepatic ischemia-reperfusion injury: targeting angiotensin II receptor-neprilysin and modulating SMAD-4/NF-κβ/JNK pathways in rats
    Abouzed, Deiaa E. Elsayed
    Bafail, Duaa Abdullah
    Refaie, Shereen Mahmoud
    Aboelez, Moustafa O.
    Elsayed, Asmaa A.
    Mallasiy, L. O.
    Bayoumy, Nervana M. K.
    Hagar, Hanan
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
  • [37] A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13
    Yoo, Kwai Han
    Lee, Su Jin
    Cho, Jinhyun
    Lee, Ki Hyeong
    Park, Keon Uk
    Kim, Ki Hwan
    Cho, Eun Kyung
    Choi, Yoon Hee
    Kim, Hye Ryun
    Kim, Hoon-Gu
    Ahn, Heui June
    Lee, Ha Yeon
    Yun, Hwan Jung
    Kang, Jin-Hyoung
    Jeong, Jaeheon
    Choi, Moon Young
    Jung, Sin-Ho
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    CANCER RESEARCH AND TREATMENT, 2019, 51 (02): : 718 - 726
1234